Early studies in European and North American cohorts identified a strong association between heterozygous R47H carriers and AD, reporting odds ratios (ORs) ranging from 2.83 to 4.59—comparable to the risk conferred by the APOE ε4 allele [6, 7]. Here, APOE is linked to Alzheimer disease.